| 臺大學術典藏 |
2021-11-22T02:27:14Z |
Evaluating the tradeoffs of a generalist parasitoid fungus, Ophiocordyceps unilateralis, on different sympatric ant hosts
|
Lin, W.-J.; Lee, Y.-I.; Liu, S.-L.; Lin, C.-C.; Chung, T.-Y.; Chou, J.-Y. |
| 淡江大學 |
2021-11-15 |
A New Method of Visual Training for Amblyopia Using Binocular Training and Virtual Reality
|
Lin, C.-C.;Chou, C.-H. |
| 臺大學術典藏 |
2021-11-11T07:33:05Z |
Investigation of the Number of Tests Required for Assaying Plasma Biomarkers Associated with Alzheimer’s Disease Using Immunomagnetic Reduction
|
Liu H.-C.; Chen H.-H.; Ho C.-S.; Chang J.-F.; Lin C.-C.; MING-JANG CHIU; Chen T.-F.; Hu C.-J.; Yan S.-H.; Sun Y.; Yang S.-Y. |
| 臺大學術典藏 |
2021-11-03T05:24:55Z |
Serial Plasma Cell-Free Circulating Tumor DNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in EGFR T790M–Positive NSCLC
|
Liao B.-C.; Hsu W.-H.; Lee J.-H.; Yang C.-Y.; Tsai T.-H.; Liao W.-Y.; Ho C.-C.; Lin C.-C.; Shih J.-Y.; CHONG-JEN YU; Soo R.A.; Yang J.C.-H. |
| 臺大學術典藏 |
2021-11-03T02:33:02Z |
Serial Plasma Cell-Free Circulating Tumor DNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in EGFR T790M–Positive NSCLC
|
Liao B.-C.; Hsu W.-H.; Lee J.-H.; Yang C.-Y.; Tsai T.-H.; Liao W.-Y.; Ho C.-C.; Lin C.-C.; JIN-YUAN SHIH; Yu C.-J.; Soo R.A.; Yang J.C.-H. |
| 臺大學術典藏 |
2021-10-27T03:22:21Z |
Phf6-null hematopoietic stem cells have enhanced self-renewal capacity and oncogenic potentials
|
Hsu Y.-C.; Chen T.-C.; Lin C.-C.; CHANG-TSU YUAN; Hsu C.-L.; Hou H.-A.; Kao C.-J.; Chuang P.-H.; Chen Y.-R.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-10-27T03:22:19Z |
Knock-out of Hopx disrupts stemness and quiescence of hematopoietic stem cells in mice
|
Lin C.-C.; Yao C.-Y.; Hsu Y.-C.; Hou H.-A.; CHANG-TSU YUAN; Li Y.-H.; Kao C.-J.; Chuang P.-H.; Chiu Y.-C.; Chen Y.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-10-27T03:22:17Z |
Mucosa-associated lymphoid tissue lymphoma with isolated endobronchial involvement
|
Liao T.-Y.; Lin C.-C.; CHANG-TSU YUAN; Lin C.-K.; Ho C.-C. |
| 臺大學術典藏 |
2021-10-27T03:22:16Z |
PD-L1 expression in megakaryocytes and its clinicopathological features in primary myelofibrosis patients
|
Lee S.-H.; Lin C.-C.; Wei C.-H.; Chang K.-P.; CHANG-TSU YUAN; Tsai C.-H.; Liu J.-H.; Hou H.-A.; Tang J.-L.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-10-26T02:34:50Z |
Effects of electromyography biofeedback-assisted relaxation on pain in patients with advanced cancer in a palliative care unit
|
Tsai P.-S.; Chen P.-L.; Lai Y.-L.; MING-BEEN LEE; Lin C.-C. |
| 臺大學術典藏 |
2021-10-26T02:34:40Z |
Finding social phobia patients from the Internet
|
Chen J.-T.; Lin C.-C.; Wang S.-C.; Liao S.-C.; Chen J.-Y.; Liu C.-Y.; MING-BEEN LEE |
| 臺大學術典藏 |
2021-10-14T02:46:20Z |
Changing trends of prostate cancer in Asia
|
Pu Y.-S.; Chiang H.-S.; Lin C.-C.; CHAO-YUAN HUANG; Huang K.-H.; Chen J. |
| 臺大學術典藏 |
2021-10-14T02:46:19Z |
Characterization of molecular events in a series of bladder urothelial carcinoma cell lines with progressive resistance to arsenic trioxide
|
Hour T.-C.; CHAO-YUAN HUANG; Lin C.-C.; Chen J.; Guan J.-Y.; Lee J.-M.; Pu Y.-S. |
| 臺大學術典藏 |
2021-10-14T02:46:18Z |
Epidermal growth factor receptor inhibitor (PD168393) potentiates cytotoxic effects of paclitaxel against androgen-independent prostate cancer cells
|
Pu Y.-S.; Hsieh M.-W.; Wang C.-W.; Liu G.-Y.; CHAO-YUAN HUANG; Lin C.-C.; Guan J.-Y.; Lin S.-R.; Hour T.-C. |
| 臺大學術典藏 |
2021-10-14T02:46:18Z |
Weekly cisplatin plus infusional high-dose 5-fluorouracil and leucovorin (P-HDFL) for metastatic urothelial carcinoma: An effective regimen with low toxicity
|
Lin C.-C.; Hsu C.-H.; CHAO-YUAN HUANG; Cheng A.-L.; Chen J.; Vogelzang N.J.; Pu Y.-S. |
| 臺大學術典藏 |
2021-10-14T02:46:18Z |
Differential expression of molecular markers in arsenic- and non-arsenic-related urothelial cancer
|
Hour T.-C.; Pu Y.-S.; Lin C.-C.; Huang S.-W.; Chen J.; Chiu A.W.; Chen C.-J.; CHAO-YUAN HUANG |
| 臺大學術典藏 |
2021-10-14T02:46:17Z |
Phase II Trial of Weekly Paclitaxel, Cisplatin Plus Infusional High Dose 5-Fluorouracil and Leucovorin for Metastatic Urothelial Carcinoma
|
Lin C.-C.; Hsu C.-H.; CHAO-YUAN HUANG; Cheng A.-L.; Vogelzang N.J.; Pu Y.-S. |
| 臺大學術典藏 |
2021-10-14T02:46:15Z |
Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: A phase II study
|
Lin C.-C.; Hsu C.-H.; CHAO-YUAN HUANG; Keng H.-Y.; Tsai Y.-C.; Huang K.-H.; Cheng A.-L.; Pu Y.-S. |
| 臺大學術典藏 |
2021-10-14T02:46:15Z |
Prognostic Factors for Metastatic Urothelial Carcinoma Treated with Cisplatin and 5-Fluorouracil-Based Regimens
|
Lin C.-C.; Hsu C.-H.; CHAO-YUAN HUANG; Tsai Y.-C.; Huang K.-H.; Cheng A.-L.; Pu Y.-S. |
| 臺大學術典藏 |
2021-10-14T02:46:14Z |
Weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in hormone-refractory prostate cancer: In vitro combined effects and a Phase II trial
|
Lin C.-C.; Hsu C.-H.; Hour T.-C.; Cheng A.-L.; CHAO-YUAN HUANG; Huang K.-H.; Chen J.; Pu Y.-S. |
| 臺大學術典藏 |
2021-10-14T02:46:11Z |
Down-regulated expression of RhoA in human conventional renal cell carcinoma
|
Pu Y.-S.; Wang C.-W.; Liu G.-Y.; Kuo Y.-Z.; CHAO-YUAN HUANG; Kang W.-Y.; Shun C.-T.; Lin C.-C.; Wu W.-J.; Hour T.-C. |
| 臺大學術典藏 |
2021-10-14T02:46:09Z |
Induction Cisplatin and Fluorouracil-Based Chemotherapy Followed by Concurrent Chemoradiation for Muscle-Invasive Bladder Cancer
|
Lin C.-C.; Hsu C.-H.; Cheng J.C.; CHAO-YUAN HUANG; Tsai Y.-C.; Hsu F.-M.; Huang K.-H.; Cheng A.-L.; Pu Y.-S. |
| 臺大學術典藏 |
2021-10-14T02:45:36Z |
A role of multimodality bladder-preserving therapy in patients with muscle-invasive bladder cancer plus hydronephrosis with or without pelvic nodal involvement
|
Chiang Y.; Cheng J.C.-H.; CHAO-YUAN HUANG; Tsai Y.-C.; Lin C.-C.; Hsu C.-H.; Cheng A.-L.; Pu Y.-S. |
| 臺大學術典藏 |
2021-10-14T02:45:34Z |
Optimal usage of radium-223 in metastatic castration-resistant prostate cancer
|
Cha T.-L.; Wu T.T.-L.; Vogelzang N.J.; CHAO-YUAN HUANG; Huang S.-P.; Lin C.-C.; Ou Y.-C.; Pang S.-T.; Shen D.H.-Y.; Wu W.-J.; Chang W.Y.-H. |
| 臺大學術典藏 |
2021-10-14T02:45:26Z |
Nuclear factor-κB overexpression is correlated with poor outcomes after multimodality bladder-preserving therapy in patients with muscle-invasive bladder cancer
|
Chiang Y.; Wang C.-C.; Tsai Y.-C.; CHAO-YUAN HUANG; Pu Y.-S.; Lin C.-C.; Cheng J.C.-H. |
